[1]吴铁鹰,刘永兰,张峻青,等.体部伽玛刀治疗Ⅰ、Ⅱ期非小细胞肺癌疗效分析[J].中国临床实用医学,2014,5(2):6-8.
[2]王碧云,杨佩浓,杨海华,等.芪胶升白胶囊治疗肺癌放疗期间白细胞抑制的效果观察[J].中国医药,2014,9(2):176-178.
[3]周际昌.实用肿瘤内科学[M].2版.北京:人民卫生出版社,2003:47-48.
[4]殷蔚伯,谷铣之.肿瘤放射治疗学[M].3版.北京:中国协和医科大学出版社,2002:1108-1110.
[5]Li Rui,Chenwei-chang,Wang Wei-peng,et al.Antioxidant activity of astragalus polysaccharides and antitumouractivity of the polysaccharides and siRNA [J].Carbohydrate polymers,2010,82(2):240-244.
[6]Williams JP,Brown SL,Georges GE,et al.Animal models for medical countermeasures to radiation exposure[J].Rad Res,2010,173(4):557-558.
[7]Van Landeghem L,Blue RE,Dehmer JJ,et al.Localized intestinal radiation and liquid diet enhance survival and permit evaluation of long-term intestinal esponses to high dose radiation in mice [J].Plos One,2012,7(12):e51310.
[8]Yongwen Zhang,Yamada.Complement activation galactan chains in a pectic arabinogalactan(AGⅡb-1) from the roots of Angelica acutiloba Kitagawa [J].Carbohydrate Polymer,1996,31:149-156.
[9]Lee SE,Yang TA.Radiation protective effects of two traditional Chinese medicine presriptions si-wu-tang and si-jun-zi-tang[J].Am J Chin Med,1999,27(3 ):387-396.
[10]国家药典委员会.中华人民共和国药典:一部[S].2010 版.北京:中国医药科技出版社,2010:196.
[11]丁海玲,李华伟,李雪花,等.复方黄芪多糖对小鼠的抗疲劳和耐缺氧作用[J].延边大学医学学报,2009,32(4):160-162.
[12]钟 灵,王振富,文德鉴,等.黄芪多糖抗衰老作用的实验研究[J].中国应用生理学杂志,2013,29(4):350-352.
[13]晏洪波,梁 文.黄芪的免疫调节及抗病毒作用[J].华南国防医学杂志,2008,22(6):69-70.
[14]王君巧,聂少平,余 强,等.灵芝多糖对免疫抑制小鼠的免疫调节和抗氧化作用[J].食品科学,2012,33(23):274-277.
[15]王 宁,李应东,刘 凯.当归、黄芪及其有效成分抗辐射作用研究概况[J].中国辐射卫生,2008,17(1):121-122.
[16]张 燕,王晓萍.中药防治放射性口腔干燥症用药规律的探讨[J].东南国防医药,2012,14(1):39-41.
[17]杨新辉,苏加利,周光华,等.体部伽玛刀疗非小细胞肺癌的效果及其影响因素[J].医学临床研究,2008,25(2):236-239.
[18]江晓肖,宋水川,陈达伟.伽玛刀治疗对胰腺癌患者外周T淋巴细胞亚群的影响[J].东南国防医药,2012,14(2):129-131.
[1]周诚忠,夏炎春,夏海波.三维适形放射治疗老年非小细胞肺癌60例[J].医学研究与战创伤救治(原医学研究生学报),2009,11(01):20.
ZHOU Cheng-zhong,XIA Yan-chun,XIA Hai-bao.Analysis of curative effect on 60 elderly non-small cell lung cancer patients treated by three-dimensional conformal radiotherapy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(05):20.
[2]洪原城,林平冬,张江灵,等.晚期非小细胞肺癌骨转移的骨相关事件
及生存分析[J].医学研究与战创伤救治(原医学研究生学报),2009,11(02):124.
HONG Yuan-cheng,LIN Ping-dong,ZHANG Jiang-ling,et al.Skeletal-related events of skeletal metastases in advanced stage non-small cell lung cancer and survival analysis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(05):124.
[3]陈芳芳 综述,李晓军 审校.细胞凋亡在介导非小细胞肺癌耐药调节中的作用[J].医学研究与战创伤救治(原医学研究生学报),2015,17(03):286.[doi:10.3969/j.issn.1672-271X.2015.03.020]
[4]周小林.CRP和Alb与初诊断的非小细胞肺癌临床病理特征联系及预后价值分析[J].医学研究与战创伤救治(原医学研究生学报),2016,18(05):489.[doi:10.3969/j.issn.1672-271X.2016.05.012]
ZHOU Xiao-lin.Prognostic evaluation of CRP and Alb in newly diagnosed non-small cell lung cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(05):489.[doi:10.3969/j.issn.1672-271X.2016.05.012]
[5]徐瑞彤,孙康俊,戴冠群,等.抗雌激素治疗对耐酪氨酸激酶抑制剂非小细胞肺癌细胞株抗增殖作用的机制探讨[J].医学研究与战创伤救治(原医学研究生学报),2017,19(06):581.[doi:10.3969/j.issn.1672-271X.2017.06.006]
XU Rui-tong,SUN Kang-jun,DAI Guan-qun,et al.The antitumor effect of anti-estrogen therapy on non-small cell lung cancer cell lines with acquired resistance to EGFR-TKI[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(05):581.[doi:10.3969/j.issn.1672-271X.2017.06.006]
[6]张驰,张久荣,童维佳,等.芪胶升白胶囊对改善非小细胞肺癌患者化疗所致中性粒细胞减少症的临床药物疗效研究与分析[J].医学研究与战创伤救治(原医学研究生学报),2018,20(01):26.[doi:10.3969/j.issn.1672-271X.2018.01.006]
ZHANG Chi,ZHANG Jiu-rong,TONG Wei-jia,et al.Study and analysis on clinical drug efficacy of Qijiaoshengbai capsule on the treatment of non-small cell lung cancer patients with neutropenia caused by chemotherapy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(05):26.[doi:10.3969/j.issn.1672-271X.2018.01.006]
[7]沈凯凯综述,吕镗烽审校.外泌体在非小细胞肺癌中的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2018,20(04):399.[doi:10.3969/j.issn.1672-271X.2018.04.016]
[8]王毅,权琳.培美曲塞与顺铂联合吉非替尼治疗对非小细胞肺癌患者T细胞亚群及细胞因子的影响[J].医学研究与战创伤救治(原医学研究生学报),2020,22(01):43.[doi:10.3969/j.issn.1672-271X.2020.01.010]
WANGYi,QUANLin.Effects of pemetrexed and cisplatin combined with gefitinib on T cell subsets and cytokines in patients with lung cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(05):43.[doi:10.3969/j.issn.1672-271X.2020.01.010]
[9]蔡猛,周光新.非小细胞肺癌骨转移的治疗研究进展[J].医学研究与战创伤救治(原医学研究生学报),2022,24(4):408.[doi:10.3969/j.issn.1672-271X.2022.04.015]
CAI Meng,ZHOU Guang-xin.Research progress in the treatment of bone metastasis in non-small cell lung cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2022,24(05):408.[doi:10.3969/j.issn.1672-271X.2022.04.015]
[10]顾晓凌,吴冠楠,王栋,等.免疫检查点抑制剂相关甲状腺不良事件对PD-1单抗治疗非小细胞肺癌的预测价值[J].医学研究与战创伤救治(原医学研究生学报),2023,25(1):7.[doi:10.3969/j.issn.1672-271X.2023.01.002]
GU Xiaoling,WU Guannan,WANG Dong,et al.Immune-related thyroid function abnormality is a prognostic factor for non-small cell lung cancer patients treated with PD-1 monoclonal antibody[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2023,25(05):7.[doi:10.3969/j.issn.1672-271X.2023.01.002]